Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31753727
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Transitional Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Urologic Neoplasms
/
Salvage Therapy
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2020
Type:
Article